PharmExec Global Marketing:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
 
| Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
February 24, 2015 | ISSUE NUMBER 18 VOL 1

Top Story
The End of Pharma Marketing — or a New Beginning?
FDA licensing approval is often touted as the essential marker of a new drug's success–but what counts far more is ensuring physicians, patients, and insurers know about the product and are willing to prescribe it, pay for it, and use it. Making this connection is the function of the marketer. Two marketing experts tell Pharm Exec how this mission critical function must change to stay relevant ...Read more

learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study: Learn more.

Social Media & Marketing
Memes: How Can Pharma Use Them?
Memes are tough to control no matter what industry you're in. And in the highly regulated, to put it mildly, environment of pharmaceutical marketing, it's safe to say that pharma companies are very limited at creating, using, and controlling these rapidly moving and dynamic idea vehicles. Casey McDonald reports
...Read more

Launch Strategy
The Seven Deadly Sins of Product Launches
As more new products vie for payer and prescriber attention, the stakes aroundlaunch success are higher than ever. Stan Bernard outlines the key traps toavoid in getting things right – when it really counts
...Read more

Behavioral Economics
The Hidden Forces of Behavioral Economics
Patients and clinicians decide to use or not to use products and brands for reasons that are not always rational. Efficacy and clinical data are often only casual factors in the choice of medications and pharmaceutical brands. In fact, an overwhelming body of evidence confirms patients and physicians alike often behave "irrationally", writes Daryl Travis
...Read more

Leadership
Pharm Exec's 2015 Emerging Pharma Leaders — Nominate Now!
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year's entries is April 15
...Read more

//ImmuDyne (Mt. Kisco, NY) hired Todd Goldman as Senior Vice President of Marketing and Sales.//Harvard Bioscience (Holliston, MA) appointed Ryan Atienza as Vice President of Sales, a newly created position, at its Denville Scientific subsidiary.//Twist Bioscience (San Francisco, MA) named Patrick J. Finn, Ph.D., as Vice President of Sales and Marketing. //Essen BioScience (Ann Arbor, MI) appointed Jim Ryder as Global Head of Sales.//

February 25–26: Speaker Programs 2015
Philadelphia, PA.


May 7–8, 2015: iPharma 2015
New York, NY.


August 11–12: Speed to Therapy Strategy Summit
Philadelphia, PA.



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Linkedin


Quick Links

Launch Blueprint

Heart Failure Health Area Wide Open for New Therapeutics

The 3S Framework for Post-Deal Growth

Pharm Exec eBooks Availabe as Apps